YoshidaGJ: Metabolic reprogramming: The emerging concept and associated therapeutic strategies. J Exp Clin Cancer Res, 2015; 34:111.
2.
Ganapathy-KanniappanS: Editorial: Cancer metabolism: Molecular targeting and implications for therapy. Front Oncol, 2017; 7:232.
3.
RoszikJ, TaneseK, and EkmekciogluS: Editorial: Targeting metabolism in cancer immunotherapy. Front Immunol, 2018; 9:2029.
4.
ZhangZ, LiY, YanX, SongQ, WangG, HuY, JiaoS, and WangJ: Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis. Cancer Med, 2019. [Epub ahead of print]; DOI: 10.1002/cam4.2024.
5.
PearceEL, PoffenbergerMC, ChangCH, and JonesRG: Fueling immunity: Insights into metabolism and lymphocyte function. Science, 2013; 342:1242454.
6.
MohamedE, Al-KhamiAA, and RodriguezPC: The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates. Cell Mol Immunol, 2018; 15:421–427.
7.
SchurichA, MagalhaesI, and MattssonJ: Metabolic regulation of CAR T cell function by the hypoxic microenvironment in solid tumors. Immunotherapy, 2019; 11:335–345.
